FDA Approved: OXCARBAZEPINE — Supplemental Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for oxcarbazepine by ANI Pharmaceuticals, Inc., updating regulatory approvals for this product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Partial-onset Seizures

Drugs mentioned

• Oxcarbazepine (Oxcarbazepine)

Snippet

SUPPL AP for OXCARBAZEPINE (OXCARBAZEPINE)